The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The future of blood‐based biomarkers for Alzheimer's disease
Open accessAbstract
Treatment of Alzheimer's disease (AD) is significantly hampered by the lack of easily accessible biomarkers that can detect disease presence and predict disease risk reliably. Fluid biomarkers of AD currently provide indications of disease stage; however, they are not robust predictors of disease progression or treatment response, and most are measured in cerebrospinal fluid, which limits their applicability. With these aspects in mind, the aim of this article is to underscore the concerted efforts of the Blood‐Based Biomarker Interest Group, an international working group of experts in the field. The points addressed include: (1) the major challenges in the development of blood‐based biomarkers of AD, including patient heterogeneity, inclusion of the “right” control population, and the blood–brain barrier; (2) the need for a clear definition of the purpose of the individual markers (e.g., prognostic, diagnostic, or monitoring therapeutic efficacy); (3) a critical evaluation of the ongoing biomarker approaches; and (4) highlighting the need for standardization of preanalytical variables and analytical methodologies used by the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationBlennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Self-citationThe projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Self-citationMcKhann, G. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1803 · Cited by 1,472
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 3×
“[54] (n 5 259) 120 known signaling proteins in plasma”
BackgroundInfluentialSelf-citationAmyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 975
Linking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972
Clark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70142-4 · Cited by 855
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A., Ringheim, A., Långström, B., & Nordberg, A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 728
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel, H., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 631
Self-citationPlasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
Hampel, H., Bürger, K., Teipel, S. J., Bokde, A. L. W., Zetterberg, H., & Blennow, K. (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.08.006 · Cited by 532
Self-citationCaspase activation precedes and leads to tangles
de Calignon, A., Fox, L. M., Pitstick, R., Carlson, G. A., Bacskai, B. J., Spires-Jones, T. L., & Hyman, B. T. (2010) · Nature · doi:10.1038/nature08890 · Cited by 517
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487
Morris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.269 · Cited by 476
Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease
Wang, S.-C., Oelze, B., & Schumacher, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002698 · Cited by 466
Proteome-based plasma biomarkers for Alzheimer's disease
Hye, A., Lynham, S., Thambisetty, M., Causevic, M., Campbell, J., Byers, H. L., Hooper, C., Rijsdijk, F., Tabrizi, S. J., Banner, S., et al. (2006) · Brain · doi:10.1093/brain/awl279 · Cited by 464
Self-citationProteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP
Josephs, K. A., Petersen, R. C., Knopman, D. S., Boeve, B. F., Whitwell, J. L., Duffy, J. R., Parisi, J. E., & Dickson, D. W. (2006) · Neurology · doi:10.1212/01.wnl.0000191307.69661.c3 · Cited by 455
Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429
Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
Doecke, J. D. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1282 · Cited by 421
α-Synuclein and neuronal cell death
Cookson, M. R. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-9 · Cited by 418
Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.-O., Westman, E., Kinsey, A., Güntert, A., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.78 · Cited by 405
Self-citationClassification of osteoarthritis biomarkers: a proposed approach
Bauer, D. C., Hunter, D. J., Abramson, S. B., Attur, M., Corr, M., Felson, D., Heinegård, D., Jordan, J. M., Kepler, T. B., Lane, N. E., et al. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.001 · Cited by 405
Prince, M. J., Prina, M. A., & Guerchet, M. (2009) · Cited by 383
Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43
Zhang, Y.-J., Xu, Y.-F., Dickey, C. A., Buratti, E., Baralle, F., Bailey, R., Pickering-Brown, S., Dickson, D., & Petrucelli, L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3421-07.2007 · Cited by 371
Evolution of Translational Omics: Lessons Learned and the Path Forward
Micheel, C., Nass, S. J., & Omenn, G. S. (2013) · Cited by 365
The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
Koyama, A., O'Brien, J., Weuve, J., Blacker, D., Metti, A. L., & Yaffe, K. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls187 · Cited by 322
Irie, F., Fitzpatrick, A. L., Lopez, O. L., Kuller, L. H., Peila, R., Newman, A. B., & Launer, L. J. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.29 · Cited by 305
Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease
Geekiyanage, H., Jicha, G. A., Nelson, P. T., & Chan, C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.026 · Cited by 294
Oxidative stress and β-amyloid protein in Alzheimer’s disease
Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies
Cohen, T. J., Lee, V. M. Y., & Trojanowski, J. Q. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.004 · Cited by 269
Self-citationBiomarkers in diabetes: hemoglobin A1c, vascular and tissue markers
Lyons, T. J., & Basu, A. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.009 · Cited by 250
Calpain-Cleavage of α-Synuclein
Dufty, B. M., Warner, L. R., Hou, S. T., Jiang, S. X., Gomez-Isla, T., Leenhouts, K. M., Oxford, J. T., Feany, M. B., Masliah, E., & Rohn, T. T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061232 · Cited by 241
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
Hu, W. T., Holtzman, D. M., Fagan, A. M., Shaw, L. M., Perrin, R., Arnold, S. E., Grossman, M., Xiong, C., Craig-Schapiro, R., Clark, C. M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318266fa70 · Cited by 241
Self-citationProteolytic Cleavage of Extracellular Secreted α-Synuclein via Matrix Metalloproteinases
Sung, J. Y., Park, S. M., Lee, C.-H., Um, J. W., Lee, H. J., Kim, J., Oh, Y. J., Lee, S.-T., Paik, S. R., & Chung, K. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503341200 · Cited by 238
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease: A Systematic Review
Herrmann, N., Chau, S. A., Kircanski, I., & Lanctôt, K. L. (2011) · Drugs · doi:10.2165/11595870-000000000-00000 · Cited by 237
Randall, J., Mörtberg, E., Provuncher, G. K., Fournier, D. R., Duffy, D. C., Rubertsson, S., Blennow, K., Zetterberg, H., & Wilson, D. H. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2012.07.027 · Cited by 230 · cited 2×
“This method is w3 logs more sensitive than conventional immunoassays for tau and is based on antibodies reacting with all tau isoforms, both normal and phosphorylated [99].”
BackgroundMethodSelf-citationKoyama, A., Okereke, O. I., Yang, T., Blacker, D., Selkoe, D. J., & Grodstein, F. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1841 · Cited by 224
Biomarkers for the Diagnosis and Prognosis of Mild Traumatic Brain Injury/Concussion
Jeter, C. B., Hergenroeder, G. W., Hylin, M. J., Redell, J. B., Moore, A. N., & Dash, P. K. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2439 · Cited by 223
Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
Soares, H. D. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1070 · Cited by 218
Self-citationXia, W., Yang, T., Shankar, G., Smith, I. M., Shen, Y., Walsh, D. M., & Selkoe, D. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.565 · Cited by 216
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
Cruchaga, C., Kauwe, J. S. K., Nowotny, P., Bales, K., Pickering, E. H., Mayo, K., Bertelsen, S., Hinrichs, A., Fagan, A. M., Holtzman, D. M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds296 · Cited by 207
Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection
Yang, L., Rieves, D., & Ganley, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1208061 · Cited by 201
Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women
Schlemmer, A. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.3.476 · Cited by 200
Evolution of Translational Omics: Lessons Learned and the Path Forward
Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials, Board on Health Care Services, Board on Health Sciences Policy, & Institute of Medicine (2012) · National Academies Press eBooks · doi:10.17226/13297 · Cited by 200
Yang, C., Tan, W., Whittle, C., Qiu, L., Cao, L., Akbarian, S., & Xu, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015878 · Cited by 189
Plasma microRNA biomarkers for detection of mild cognitive impairment
Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., & Umansky, S. R. (2012) · Aging · doi:10.18632/aging.100486 · Cited by 188
CSF biomarkers cutoffs: The importance of coincident neuropathological diseases
Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182 · cited 1×
“3) [140].”
Self-citationBlood-Based Biomarkers of Alzheimer's Disease: Challenging but Feasible
Thambisetty, M., & Lovestone, S. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.84 · Cited by 182
Self-citationSunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.021 · Cited by 179
Self-citationFactors affecting Aβ plasma levels and their utility as biomarkers in ADNI
Toledo, J. B., Vanderstichele, H., Figurski, M., Aisen, P. S., Petersen, R. C., Weiner, M. W., Jack, C. R., Jagust, W., Decarli, C., Toga, A. W., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0861-8 · Cited by 177
Self-citationDiagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Han, M., Nagele, E., DeMarshall, C., Acharya, N., & Nagele, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032383 · Cited by 176
Meta-Analysis of Plasma Amyloid-β levels in Alzheimer's Disease
Song, F., Poljak, A., Valenzuela, M., Mayeux, R. P., Smythe, G. A., & Sachdev, P. S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101977 · Cited by 174
Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease
Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Darby, E. J., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110405 · Cited by 173
Lipidomics of Alzheimer's disease: current status
Wood, P. L. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt103 · Cited by 167
Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
Schneider, P., Hampel, H. J., & Büerger, K. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00104.x · Cited by 165
Self-citationDiagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Nagele, E. P., Han, M. C., DeMarshall, C. A., Belinka, B. A., & Nagele, R. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023112 · Cited by 164
Biomarkers in Alzheimer's disease drug development
Blennow, K. (2010) · Nature Medicine · doi:10.1038/nm.2221 · Cited by 162
Self-citationBiological markers of amyloid β-related mechanisms in Alzheimer's disease
Hampel, H., Shen, Y., Walsh, D. M., Aisen, P., Shaw, L. M., Zetterberg, H., Trojanowski, J. Q., & Blennow, K. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.024 · Cited by 160
Self-citationDiurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis
Kong, S. Y., Stabler, T. V., Criscione, L. G., Elliott, A. L., Jordan, J. M., & Kraus, V. B. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21977 · Cited by 160
O'Bryant, S. E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., Edwards, M., Graff-Radford, N., Doody, R., Diaz-Arrastia, R., for the Texas Alzheimer's Research & Care Consortium, et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028092 · Cited by 158
Self-citationMitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood
Lunnon, K., Ibrahim, Z. M., Proitsi, P., Lourdusamy, A., Newhouse, S., Sattlecker, M., Furney, S. J., Saleem, M., Soininen, H. S., Kłoszewska, I., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111592 · Cited by 158
Self-citationKarsdal, M. A., Henriksen, K., Leeming, D. J., WOODWORTH, T. G., Vassiliadis, E., & Bay‐Jensen, A. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.03.015 · Cited by 155
Self-citationHampel, H. J., Lista, S., & Khachaturian, Z. S. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2116 · Cited by 152
Self-citationτ Proteins in Serum Predict Outcome After Severe Traumatic Brain Injury
Liliang, P., Liang, C.-L., Weng, H., Lu, K., Wang, K., Chen, H., & Chuang, J. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.12.022 · Cited by 151
Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
Gupta, V. B., Laws, S. M., Villemagne, V. L., Ames, D., Bush, A. I., Ellis, K. A., Lui, J. K., Masters, C., Rowe, C. C., Szoeke, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318211c352 · Cited by 149
Metabolomic changes in autopsy‐confirmed Alzheimer's disease
Kaddurah‐Daouk, R., Rozen, S., Matson, W. R., Han, X., Hulette, C. M., Burke, J. R., Doraiswamy, P. M., & Welsh-Bohmer, K. A. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.001 · Cited by 149
Systematic Review of Clinical Research on Biomarkers for Pediatric Traumatic Brain Injury
Papa, L., Ramia, M. M., Kelly, J. M., Burks, S. S., Pawlowicz, A., & Berger, R. P. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2545 · Cited by 146
Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma
Neselius, S., Zetterberg, H., Blennow, K., Randall, J., Wilson, D. M., Marcusson, J. O., & Brisby, H. (2013) · Brain Injury · doi:10.3109/02699052.2012.750752 · Cited by 143
Self-citationKarsdal, M. A., Henriksen, K., Leeming, D. J., Mitchell, P. G., Duffin, K. L., Barascuk, N., Klickstein, L. B., Aggarwal, P., Nemirovskiy, O. V., Byrjalsen, I., et al. (2009) · Biomarkers · doi:10.1080/13547500902777608 · Cited by 140
Self-citationTelomere length is age-dependent and reduced in monocytes of Alzheimer patients
Hochstrasser, T., Marksteiner, J., & Humpel, C. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.11.012 · Cited by 137
Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease
Lukens, J. N., Deerlin, V. M. V., Clark, C. M., Xie, S. X., & Johnson, F. B. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.666 · Cited by 137
Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
Björkqvist, M., Ohlsson, M., Minthon, L., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029868 · Cited by 135
Biomarkers in Alzheimer's disease drug development
Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 134
Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
Thambisetty, M., Simmons, A., Hye, A., Campbell, J., Westman, E., Zhang, Y., Wahlund, L., Kinsey, A. M., Čaušević, M., Killick, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028527 · Cited by 131
Self-citationCruchaga, C., Kauwe, J. S. K., Mayo, K., Spiegel, N., Bertelsen, S., Nowotny, P., Shah, A. R., Abraham, R., Hollingworth, P., Harold, D., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001101 · Cited by 128 · cited 1×
“In fact, recent work has begun to take this approach [45–50].”
BackgroundSelf-citationInflammatory markers in coronary heart disease
Madjid, M., & Willerson, J. T. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr043 · Cited by 123
Soares, H. D., Chen, Y., Sabbagh, M. N., Rohrer, A., Schrijvers, E. M. C., & Breteler, M. M. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05066.x · Cited by 121
Self-citationKarsdal, M. A., WOODWORTH, T. G., Henriksen, K., Maksymowych, W. P., Genant, H. K., Vergnaud, P., Christiansen, C., Schubert, T., Qvist, P., Schett, G. A., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3280 · Cited by 120
Self-citationA Blood Gene Expression Marker of Early Alzheimer's Disease
Lunnon, K., Sattlecker, M., Furney, S. J., Coppola, G., Simmons, A., Proitsi, P., Lupton, M. K., Lourdusamy, A., Johnston, C., Soininen, H. S., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121363 · Cited by 115
Self-citationA Gene Expression Pattern in Blood for the Early Detection of Alzheimer's Disease
Booij, B. B., Lindahl, T., Wetterberg, P., Skaane, N. V., Sæbø, S., Feten, G., Rye, P. D., Kristiansen, L., Hagen, N., Jensen, M., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101518 · Cited by 114
Self-citationDecreased C-Reactive Protein Levels in Alzheimer Disease
O'Bryant, S. E., Waring, S. C., Hobson, V., Hall, J. R., Moore, C. B., Bottiglieri, T., Massman, P., & Diaz-Arrastia, R. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709351832 · Cited by 103
Self-citationIncidence of Post‐Dural Puncture Headache in Research Volunteers
de Almeida, S. M., Shumaker, S. D., Leblanc, S. K. D., Delaney, P., Marquie‐Beck, J., Ueland, S., Alexander, T. J., & Ellis, R. J. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01959.x · Cited by 103
A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
Portelius, E., Dean, R. A., Gustavsson, M. K., Andréasson, U., Zetterberg, H., Siemers, E., & Blennow, K. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt30 · Cited by 101
Self-citationPlasma Based Markers of [11C] PiB-PET Brain Amyloid Burden
Kiddle, S. J., Thambisetty, M., Simmons, A., Riddoch-Contreras, J., Hye, A., Westman, E., Pike, I., Ward, M., Johnston, C., Lupton, M. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044260 · Cited by 100
Self-citationThe future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation
Klunk, W. E., & Mathis, C. A. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283168e1a · Cited by 99
Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants
Mayeux, R. P., & Schupf, N. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.004 · Cited by 98
Blood-Cerebrospinal Fluid Barrier Permeability in Alzheimer's Disease
Chalbot, S., Zetterberg, H., Blennow, K., Fladby, T., Andreasen, N., Grundke, I., & Iqbal, K. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101959 · Cited by 93
Self-citationAxonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells
Brunholz, S., Sisodia, S., Lorenzo, A., Deyts, C., Kins, S., & Morfini, G. (2012) · Experimental Brain Research · doi:10.1007/s00221-011-2870-1 · Cited by 92
Reifert, J. R., Hartung-Cranston, D., & Feinstein, S. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234674 · Cited by 92
Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS
Ito, D., & Suzuki, N. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343365 · Cited by 91
Methods for Analysis of Amyloid-β Aggregates
Bruggink, K. A., Müller, M., Kuiperij, H. B., & Verbeek, M. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111421 · Cited by 86
CSF Biomarkers: Pinpointing Alzheimer Pathogenesis
Mattsson, N., Blennow, K., & Zetterberg, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04944.x · Cited by 86
Self-citationCaspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease
Rohn, T. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.094 · Cited by 84
Mapping the Road Forward in Alzheimer’s Disease
Holtzman, D. M., Goate, A., Kelly, J. W., & Sperling, R. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003529 · Cited by 82
α-Synuclein in Parkinson disease and other neurodegenerative disorders
Eller, M., & Williams, D. R. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.077 · Cited by 81
Llano, D. A., Devanarayan, V., & Simon, A. J. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31826d597a · Cited by 78
Britschgi, M., Rufibach, K., Huang, S. L. B., Clark, C. M., Kaye, J. A., Li, G., Peskind, E. R., Quinn, J. F., Galasko, D. R., & Wyss‐Coray, T. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.008862 · Cited by 76
Self-citationProteome-Based Plasma Markers of Brain Amyloid-β Deposition in Non-Demented Older Individuals
Thambisetty, M., Tripaldi, R., Riddoch‐Contreras, J., Hye, A., An, Y., Campbell, J., Sojkova, J., Kinsey, A. M., Lynham, S., Zhou, Y., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101350 · Cited by 75
Self-citationKarsdal, M. A., Byrjalsen, I., Bay‐Jensen, A., Henriksen, K., Riis, B., & Christiansen, C. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-125 · Cited by 75
Self-citationThe role of APP proteolytic processing in lipid metabolism
Grimm, M. O. W., Rothhaar, T. L., & Hartmann, T. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2975-6 · Cited by 75
The use of SELDI-TOF MS in the search for biological markers of Alzheimer’s disease
Watt, A. D. (2013) · Minerva Access (University of Melbourne) · Cited by 75
Mattsson, N., Rajendran, L., Zetterberg, H., Gustavsson, M. K., Andréasson, U., Olsson, M., Brinkmalm, G., Lundkvist, J., Jacobson, L. H., Perrot, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031084 · Cited by 74
Self-citationA Novel Blood Test for the Early Detection of Alzheimer's Disease
Rye, P. D., Boonstra, B., Grave, G., Lindahl, T., Kristiansen, L., Andersen, H., Horndalsveen, P. O., Nygaard, H. A., Naik, M., Hoprekstad, D., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101521 · Cited by 71
Self-citationConclusions and Future Perspectives
Fanelli, R. (2011) · doi:10.1002/9781118000816.ch19 · Cited by 70
Fehlbaum, P., on behalf of the EHTAD/002 study group, Sol, O., Désiré, L., Touchon, J., DANTOINE, T. F., Vercelletto, M., Gabelle, A., Jarrige, A.-C., Haddad, R., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120637 · Cited by 70
Self-citationWu, G., Sankaranarayanan, S., Wong, J., Tugusheva, K., Michener, M. S., Shi, X., Cook, J. J., Simon, A. J., & Savage, M. J. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23122 · Cited by 68
Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
Rissman, R. A., Trojanowski, J. Q., Shaw, L. M. J., & Aisen, P. S. S. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0772-4 · Cited by 68
Self-citationAndersson, M., Petersson, I. F., Karlsson, K. E., Jonsson, E. N., Månsson, B., Heinegård, D. K., & Saxne, T. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.051292 · Cited by 68
Colasanti, T., Barbati, C., Rosano, G. M. C., Malorni, W., & Ortona, E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.07.008 · Cited by 65
Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Rosa, G. D., Salzano, G., Caraglia, M., & Abbruzzese, A. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356943 · Cited by 62
Biological and methodical challenges of blood-based proteomics in the field of neurological research
Lista, S., Faltraco, F., & Hampel, H. J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.006 · Cited by 61
Self-citationDevelopment of biomarkers for multiple sclerosis as a neurodegenerative disorder
Ziemann, U., Wahl, M., Hattingen, E., & Tumani, H. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.007 · Cited by 59
Association Between ApoE Phenotypes and Telomere Erosion in Alzheimer’s Disease
Takata, Y., Kikukawa, M., Hanyu, H., Koyama, S., Shimizu, S., Umahara, T., Sakurai, H., Iwamoto, T., Ohyashiki, K., & Ohyashiki, J. H. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr185 · Cited by 54
Karsdal, M. A., Byrjalsen, I., Riis, B., & Christiansen, C. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-12 · Cited by 53
Self-citationVariability in Blood-Based Amyloid-β Assays: The Need for Consensus on Pre-Analytical Processing
Watt, A. D., Perez, K. A., Rembach, A., Masters, C. L., Villemagne, V. L., & Barnham, K. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120058 · Cited by 43
Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease
Noguchi‐Shinohara, M., Hamaguchi, T., Nozaki, I., Sakai, K., & Yamada, M. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5960-x · Cited by 43
Gustaw‐Rothenberg, K., Siedlak, S. L., Bonda, D., Lerner, A. J., Tabaton, M., Perry, G. L., & Smith, M. A. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.003 · Cited by 42
Chen, Y.-S., Lim, S.-C., Chen, M.-H., Quinlan, R. A., & Perng, M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.06.017 · Cited by 42
Henriksen, K., Wang, Y., Sørensen, M. G., Barascuk, N., Suhy, J., Pedersen, J. T., Duffin, K. L., Dean, R. A., Pajak, M., Christiansen, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064990 · Cited by 42
Self-citationBüerger, K., Ernst, A. S., Ewers, M., Uspenskaya, O., Omerovic, M., Morgenthaler, N. G., Knauer, K., Bergmann, A., & Hampel, H. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.032 · Cited by 41
Self-citationInfluence of food intake on the bioavailability and efficacy of oral calcitonin
Karsdal, M. A., Byrjalsen, I., Azria, M., Arnold, M., Choi, L., Riis, B. J., & Christiansen, C. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03371.x · Cited by 39
Self-citationPotential Peripheral Biomarkers for the Diagnosis of Alzheimer′s Disease
Patel, S. V., Shah, R. J., Coleman, P. D., & Sabbagh, M. N. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/572495 · Cited by 37
Chang, A. M., Maisel, A. S., & Hollander, J. E. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2008.08.013 · Cited by 35
Effect of human cerebrospinal fluid sampling frequency on amyloid‐β levels
Li, J., Llano, D. A., Ellis, T. A., LeBlond, D. J., Bhathena, A., Jhee, S. S., Ereshefsky, L., Lenz, R. A., & Waring, J. F. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.900 · Cited by 33
Ávila, J. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.157 · Cited by 33
Koyama, A. K., Okereke, O. I., Yang, T., Selkoe, D. J., & Grodstein, F. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.923 · Cited by 33
Büerger, K., Uspenskaya, O., Hartmann, O., Hansson, O., Minthon, L., Blennow, K., Moeller, H., Teipel, S. J., Ernst, A. S., Bergmann, A., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05872oli · Cited by 31
Self-citationCirculating immune complexes of Aβ and IgM in plasma of patients with Alzheimer’s disease
Marcello, A., Wirths, O., Schneider-Axmann, T., Degerman-Gunnarsson, M., Lannfelt, L., & Bayer, T. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0224-y · Cited by 27
Translational proteomics in Alzheimer's disease and related disorders
Ghidoni, R., Paterlini, A., & Benussi, L. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.10.012 · Cited by 26
Sambanis, C., Τζιόμαλος, Κ., Kountana, E., Kakavas, N., Zografou, I., Balaska, A., Koulas, G., Karagiannis, A. I., & Zamboulis, C. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0014-7 · Cited by 22
PIIANP and HELIXII diurnal variation
Quintana, D. J., Garnero, P., Huebner, J. L., Tabassi, N. C.-B., & Kraus, V. B. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.03.006 · Cited by 22
Belabani, C., Rajasekharan, S., Poupon, V., Johnson, T., & Bar‐Or, A. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.08.002 · Cited by 18
Wang, Y., Sørensen, M. G., Zheng, Q., Zhang, C., Karsdal, M. A., & Henriksen, K. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/209409 · Cited by 14
Self-citationAntigen-Bound and Free β-Amyloid Autoantibodies in Serum of Healthy Adults
Maftei, M., Thurm, F., Leirer, V. M., Arnim, C. A. F. V., Elbert, T. R., Przybylski, M., Kolassa, I., & Manea, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044516 · Cited by 12
Biomarkers reflecting different facets of Alzheimer’s disease
Zetterberg, H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02275.x · Cited by 11
Research works printed but not linked: 6
- Tanne J.H., 2012, US scientists discuss early detection and treatment of Alzheimer's disease, BMJ, 344, e1068, 10.1136/bmj.e1068 · doi:10.1136/bmj.e1068
- Llano D.A., 2012, Alzheimer Dis Assoc Disord
- 10.1007/s12031-010-9403-4 · doi:10.1007/s12031-010-9403-4
- Neselius S., 2012, Brain Injury
- 10.1016/j.joca.2005.05.004 · doi:10.1016/j.joca.2005.05.004
- U.S. Food and Drug Administration, 2001, Guidance for industry: bioanalytical method validation
Cited by
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Self-citationPreclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citationMasters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853
Self-citationHigh performance plasma amyloid-β biomarkers for Alzheimer's disease
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Doré, V., Fowler, C., Li, Q.-X., Martins, R., Rowe, C., et al. (2018) · Nature · doi:10.1038/nature25456 · Cited by 1,681
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Metadata
- Authors
- Henriksen, K., O'Bryant, S. E., Hampel, H., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H., Bazenet, C., Sjögren, M., Hu, W., Lovestone, S., Karsdal, M. A., Weiner, M. W., & Blood‐Based Biomarker Interest Group
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2013-07-15
- Volume
- 10
- Issue
- 1
- Pages
- 115-131
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W1968790254
- Cited by
- 313
- References
- 141
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Vetenskapsrådet (14002)
- National Institutes of Health
- National Institute on Aging (R01AG039389)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.